IP Verse

Osiris Therapeutics competitive analysis

Latest patents of Osiris Therapeutics opposed by its competitors

Explore Osiris Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2298864
Oct 11, 2017Mesenchymal Stem Cells And Uses Therefor1
EP2298862
Aug 30, 2017Mesenchymal Stem Cells And Uses Therefor1
EP2318519
Oct 5, 2016Purified Mesenchymal Stem Cell Compositions And Methods Of Purifying Mesenchymal Stem Cell Compositions4
EP2298863
Jul 22, 2015Mesenchymal Stem Cells And Uses Therefor1

Latest PTAB cases involving Osiris Therapeutics

Discover the latest PTAB cases involving Osiris Therapeutics, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Osiris Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
OSIRIS THERAPEUTICS - 7 - -
BRANTSANDPATENTS BVBA2 - - -
CHIESI FARMACEUTICI1122 - -
FRIEDRICH, RAINER6 - - -